Cigna Corporation is a global health service company that provides a comprehensive range of health insurance products and services. The company operates across various sectors, including medical, dental, disability, life, and accident insurance, offering coverage to individuals and families, as well as employer-sponsored group plans. Additionally, Cigna delivers integrated health services, such as pharmacy management, behavioral health support, and wellness programs, focusing on improving health outcomes and enhancing the overall well-being of its members. Through its innovative approaches, Cigna aims to create a seamless healthcare experience while addressing the diverse needs of its customers. Read More
The prescription drug market still runs through three gatekeepers— CVS Caremark (NYSE: CVS), Cigna’s Express Scripts (NYSE: CI) , and UnitedHealth’s OptumRx (NYSE: UNH) —but the regulatory vise has squeezed out their most profitable practices. The stocks have already taken a beating but might go lower unless they take action now. This disruption in the market creates an opening for alternatives. Wellgistics Health (NASDAQ: WGRX) is building a blockchain and smart‑contract platform designed to monetize prescription flows without relying on the opaque spread pricing and rebate games now under attack. They have exactly what the PBMs need after this crackdown. Additionally, through their partner DataVault, they have the IP to usher in a true digital prescription that cannot be tampered with and contains its own audit trail.
Over the past six months, Molina Healthcare’s shares (currently trading at $145.75) have posted a disappointing 16.6% loss, well below the S&P 500’s 6.5% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
The "golden era" of the managed care sector came to an abrupt and painful halt this year, as UnitedHealth Group (NYSE: UNH) reported a staggering 16% decline in full-year 2025 net profits. This downturn, revealed in late January 2026, was driven by a "perfect storm" of rising medical utilization and
For decades, small and mid-sized businesses have been led to believe that soaring health insurance premiums are unavoidable. According to a veteran benefits broker with 20 years of experience, that belief may be the biggest lie in health insurance.
Health insurance company Alignment Healthcare (NASDAQ:ALHC)
will be reporting results this Thursday after market hours. Here’s what investors should know.
As of late February 2026, the U.S. stock market has reached a definitive turning point that many analysts have predicted for years: the era of "narrow leadership" is officially ending. While the S&P 500 recently crossed the historic 7,000-point threshold, the real story isn't the headline number,
As of February 20, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnetonka-based behemoth was the undisputed gold standard of the healthcare sector—a diversified "compounder" that consistently outpaced the S&P 500 while revolutionizing the way medical care is financed and delivered. However, the dawn of 2026 has brought unprecedented [...]
As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector SPDR Fund (NYSE Arca: XLV) posted a robust 1.1% advance this week, standing in stark contrast
Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the quarter’s performance to robust expansion in its EverNorth specialty and care services, successful adoption of biosimilars, and operational discipline across its health benefits business. CEO David Cordani highlighted the company’s strategic investments, including the new pharmacy benefits model and expanded specialty offerings, noting, "We further expanded our specialty capabilities to serve hospitals and health systems, in part with our new investment in Shields Health Solutions." Cordani also emphasized Cigna’s focus on improving affordability and customer experience, particularly through initiatives like the Clarity solution and ongoing efforts to enhance digital engagement.
As of February 11, 2026, Humana Inc. (NYSE: HUM) finds itself at a historic crossroads. Once the darling of the managed care sector, the Louisville-based insurer is currently navigating a "perfect storm" of regulatory tightening, rising medical utilization, and a catastrophic decline in quality bonus payments. Today’s research deep-dive follows a volatile morning on Wall [...]
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted record-breaking revenue of $402.1 billion for the full year 2025, surpassing Wall Street expectations, its stock dipped nearly 2.5%
In a move that marks a definitive shift in the American pharmaceutical supply chain, The Cigna Group (NYSE: CI) has reached a comprehensive settlement with the Federal Trade Commission (FTC) to resolve a contentious lawsuit regarding the pricing of insulin. Announced in early February 2026, the agreement effectively ends years
The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $72.5 billion. On the other hand, the company’s full-year revenue guidance of $280 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $8.08 per share was 2.5% above analysts’ consensus estimates.
FTC finalizes a settlement with Cigna's Express Scripts to curb insulin pricing practices, projecting $7 billion in patient savings as Cigna posts strong earnings and raises its dividend.
